Laboratory for Biophysics of Macromolecular Aggregates, Institute of Biomedical Engineering and Measurements, Wroclaw Technical University, Pl. Grunwaldzki 13, Wroclaw, Poland.
J Fluoresc. 2010 Nov;20(6):1139-57. doi: 10.1007/s10895-010-0665-6.
The characterization of small molecules requires identification and evaluation of several predictive parameters, when selecting compounds for pharmacological applications and/or determining their toxicity. A number of them are correlated with the compound interaction with biological membranes and/or capacity to cross them. The knowledge of the extent of adsorption, partition coefficient and permeability along with the compound ability to alter membrane properties are critical for such studies. Lipid bilayers are frequently used as the adequate experimental models of a biological membrane despite their simple structure and a limited number of components. A significant number of the biologically relevant lipid bilayer properties are related to its electrostatics. Three electrostatic potentials were defined for the lipid bilayer; the intrinsic or induced surface electrostatic potential, the dipole potential and the membrane potential. Each of them was measured with dedicated methodologies. The complex measurement protocols and technically demanding instrumentation made the development of efficient HTS approaches for complete characterization of membrane electrostatics practically impossible. However, the rapid development of fluorescence techniques accompanied by rapid growth in diversity and number of dedicated fluorescent probes enabled characterization of lipid bilayer electrostatics in a moderately simple manner. Technically advanced, compact and automated workstations, capable of measuring practically all fluorescence parameters, are now available. Therefore, the proper selection of fluorescent probes with measuring procedures can be designed to evaluate drug candidates in context of their ability to alter membrane electrostatics. In the paper we present a critical review of available fluorescence methods, useful for the membrane electrostatics evaluation and discuss the feasibility of their adaptation to HTS procedures. The significance of the presented methodology is even greater considering the rapid growth of advanced drug formulations, where electrostatics is an important parameter for production processes and pharmacokinetics of the product. Finally, the potential of the membrane electrostatics to emerge as a viable pharmacological target is indicated and fluorescence techniques capable to evaluate this potential are presented.
小分子的特性需要确定和评估几个预测参数,这些参数在选择用于药理学应用的化合物时很重要,或者在确定它们的毒性时也很重要。其中许多参数与化合物与生物膜的相互作用和/或穿透它们的能力有关。了解吸附程度、分配系数和渗透性以及化合物改变膜性质的能力对于这些研究至关重要。尽管脂质双层的结构简单,组成成分有限,但它们经常被用作生物膜的合适实验模型。许多与生物学相关的脂质双层性质与其静电特性有关。脂质双层有三种静电势:固有或诱导的表面静电势、偶极势和膜电位。每种电势都用专门的方法进行测量。复杂的测量方案和技术要求高的仪器设备使得开发有效的高通量筛选方法来全面表征膜静电特性在实践中几乎不可能。然而,荧光技术的快速发展,伴随着荧光探针数量和种类的快速增加,使得以一种相对简单的方式对脂质双层静电特性进行特征描述成为可能。现在,技术先进、紧凑且自动化的工作站已经可以测量几乎所有的荧光参数。因此,选择合适的荧光探针并设计测量程序,可以用来评估候选药物改变膜静电特性的能力。本文对现有的荧光方法进行了批判性的回顾,这些方法对膜静电特性的评估很有用,并讨论了将其适应高通量筛选程序的可行性。考虑到先进药物制剂的快速发展,静电特性是生产过程和产品药代动力学的一个重要参数,因此,所提出的方法的意义更加重大。最后,还指出了膜静电特性作为可行的药理学靶点的潜力,并提出了能够评估这种潜力的荧光技术。